HomeTreatment

Treatment

TheraCryf’s SFX-01 Exhibits Promise in Most cancers Therapy

Evgen Pharma (GB:TCF) has launched an replace. TheraCryf plc has introduced that analysis on their drug SFX-01 as a radiosensitiser in Rhabdomyosarcoma, a standard...

New wi-fi LED gadget makes use of mild to destroy ‘deep-seated cancers’

For some cancers, mild affords a robust, minimally-invasive therapy. Nonetheless, this light-activated drug remedy works wonders on floor cancers, however deeper ones are...

Overcoming chemotherapy resistance in pancreatic most cancers

Researchers have found that pancreatic most cancers’s resistance to chemotherapy is said to the bodily stiffness of the extracellular matrix. Scientists at Stanford...

Hot Topics